Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer

Chest

Volumn 128, Issue 1, 2005, Pages 250-255

  Abou Jawde, Rony M ^a   Mekhail, Tarek ^a   Adelstein, David J ^a   Rybicki, Lisa A ^a   Mazzone, Peter J ^a   Caroll, Marjone A ^a   Rice, Thomas W ^a  

^a NONE

Author keywords

Diffusion capacity of the lung for carbon monoxide; Esophageal cancer; Postoperative acute respiratory complication; Pulmonary function; Radiation therapy

Indexed keywords

CARBON MONOXIDE; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ACUTE RESPIRATORY TRACT DISEASE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DEMOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FORCED EXPIRATORY VOLUME; GAS EXCHANGE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE ACUTE RESPIRATORY COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; REVIEW;

EID: 22244470405     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.1.250     Document Type: Article

References (33)

1. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339:1979-1984
2. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-467
3. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19:305-313
4. Hulscher JB. Tijssen JG, Obertop H, et al. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001; 72:306-313
5. Scholz J, Steinhofel U, Durig M, et al. Postoperative pulmonary complications in patients with esophageal cancer. Clin Invest 1993; 71:294-298
6. Doty JR, Salazar JD, Forastiere AA, et al. Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy. Ann Thorac Surg 2002; 74:227-231
7. Chidel MA, Rice TW, Adelstein DJ, et al. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy. Radiology 1999; 213:67-72
8. Adelstein DJ, Rice TW, Becker M, et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997; 80:1011-1020
9. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337:161-167
10. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73:1779-1784
11. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy; the second Scandinavian trial in esophageal cancer. World J Surg 1992; 16:1104-1109; discussion 1110
12. Keller SM, Ryan LM, Coia LR, et al. High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: results of a phase II study of the Eastern Cooperative Oncology Group. Cancer 1998;83:1908-1916
13. Tamim WZ, Davidson RS, Quinlan RM, et al. Neoadjuvant chemoradiotherapy for esophageal cancer: is it worthwhile? Arch Surg 1998; 133:722-726
14. Lew JI, Gooding WE, Ribeiro U Jr, et al. Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg 2001; 136:737-742; discussion 743
15. Adelstein DJ, Rice TW, Rybicki LA, et al. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol 2000; 18:2032-2039
16. Adelstein DJ RT, Rybicki LA, et al. Accelerated multimodality therapy for locoregionally (LR) advanced carcinoma of the esophagus and gastroesophageal junction (GEJ). Proc Am Soc Clin Oncol 2003; 22:273
17. Braunwald EFA, Kasper D, et al. Harrison's principles of internal medicine. 15th ed. New York, NY: McGraw Hill, 2001; 1523
18. Nagawa H, Kobori O, Muto T. Prediction of pulmonary complications after transthoracic oesophagectomy. Br J Surg 1994; 81:860-862
19. Avendano CE, Flume PA, Silvestri GA, et al. Pulmonary complications after esophagectomy. Ann Thorac Surg 2002; 73:922-926
20. Liedman B. Predictors; of postoperative morbidity and mortality after surgery for gastro-oesophageal carcinomas. Eur J Surg 1995; 161:173-180
21. Fan ST, Lau WY, Yip WC, et al. Prediction of postoperative pulmonary complications in oesophagogastric cancer surgery. Br J Surg 1987; 74:408-410
22. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359:1727-1733
23. Liedman B, Johnsson E, Merke C, et al. Preoperative adjuvant radiochemotherapy may increase the risk in patients undergoing thoracoabdominal esophageal resections. Dig Surg 2001; 18:169-175
24. Raoul JL, Le Prise E, Meunier B, et al. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma. Int J Radiat Oncol Biol Phys 1998; 42:29-34
25. Adham M, Baulieux J, Mornex F, et al. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus. Cancer 2000; 89:946-954
26. Swisher SG, Holmes EC, Hunt KK, et al. The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg 1996; 131:819-824; discussion 824-815
27. Fauci ABE, Isselbacher K, Wilson J. Harrison's principles of internal medicine. 14th ed. New York, NY: McGraw-Hill, 1998
28. Duprat G Jr, Chalaoui J, Sylvestre J, et al. Pulmonary complications of multimodality therapy for esophageal carcinoma. Can Assoc Radiol J 1987; 38:27-31
29. Nagamatsu Y, Shima I, Yamana H, et al. Preoperative evaluation of cardiopulmonary reserve with the use of expired gas analysis during exercise testing in patients with squamous cell carcinoma of the thoracic esophagus. J Thorac Cardiovasc Surg 2001; 121:1064-1068
30. Ferguson MK, Little L, Rizzo L, et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg 1988;96:894-900
31. Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989; 139:902-910
32. Handy JR Jr, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002; 122:21-30
33. Videtic GM, Stitt LW, Ash RB, et al. Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation. Lung Cancer 2004; 43:159-166